InVivo Therapeutics(NVIV) - 2023 Q1 - Quarterly Report

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 InVivo Therapeutics Holdings Corp. (Exact name of registrant as specified in its charter) (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number) Nevada 36-4528166 One Kendall Square, Suite B14402 Cambridge, MA 02139 (Address of principal executive offices) (Zip code) For the ...